Article
Circulating inflammatory ILC2s as a biomarker of gastric cancer progression
2026-05-01
Abstract excerpt
Gastric cancer is frequently diagnosed at an advanced stage, contributing to poor patient outcomes and highlighting the need for blood-based biomarkers that can detect disease earlier and track progression. We previously showed that a tuft cell-IL25-type 2 innate lymphoid cell (ILC2) circuit promotes gastric metaplasia and gastric tumour development, but whether this pathway gives rise to a circulating ILC2 popula...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e8208cbf-3010-537b-8995-dc3423a0d74b
- DOI
- 10.64898/2026.04.28.721482
